Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PATIENT SAFETY”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05324592
What this trial is testing

Safety and Efficacy of 9MW0813 in Subjects With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Mabwell (Shanghai) Bioscience Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT03046992
What this trial is testing

Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLC

Who this might be right for
EGFR Gene Mutation
Yuhan Corporation 224
Testing effectiveness (Phase 2)Ended earlyNCT02780700
What this trial is testing

Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]

Who this might be right for
Colorectal Neoplasms
Boehringer Ingelheim 1
Testing effectiveness (Phase 2)Study completedNCT00388011
What this trial is testing

Efficacy and Safety of Intranasal Morphine for Pain After Bunion Surgery

Who this might be right for
Hallux Valgus
Javelin Pharmaceuticals 187
Testing effectiveness (Phase 2)Study completedNCT01417936
What this trial is testing

Sym004 in SCCHN Patients Failing Anti-EGFR Based Therapy

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
Symphogen A/S 26
Early research (Phase 1)Study completedNCT00345800
What this trial is testing

Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes

Who this might be right for
Narcolepsy With Cataplexy
UCB Pharma SA 25
Early research (Phase 1)Study completedNCT05372107
What this trial is testing

AG-80308 in Dry Eye Patients

Who this might be right for
Dry Eye Disease
Allgenesis Biotherapeutics Inc. 84
Large-scale testing (Phase 3)Study completedNCT00677807
What this trial is testing

Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
COPD
Novartis 415
Not applicableLooking for participantsNCT07233811
What this trial is testing

Day Care in Robotic Surgery Hysterectomy. Investigate Quality of Life and Safety With Same Day Discharge After Robotic Hysterectomy for Patients With Benign and Malignant Disease. A Multicenter Randomized Study With 3 Hospitals in Stockholm Sweden.

Who this might be right for
HysterectomySame Day DischargeRobotic Surgical Procedures
Karolinska Institutet 300
Large-scale testing (Phase 3)Study completedNCT00616811
What this trial is testing

Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 148
Testing effectiveness (Phase 2)Active Not RecruitingNCT05768711
What this trial is testing

Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR)

Who this might be right for
Chronic Myeloid Leukemia
Groupe Francophone des Myelodysplasies 44
Early research (Phase 1)Looking for participantsNCT05877300
What this trial is testing

Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement

Who this might be right for
Esophageal Diseases
Harvard Apparatus Regenerative Technology, Inc. 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06487000
What this trial is testing

Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Enzychem Lifesciences Corporation 150
Large-scale testing (Phase 3)Study completedNCT02558400
What this trial is testing

Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Aerie Pharmaceuticals 718
Post-approval studies (Phase 4)Study completedNCT04331600
What this trial is testing

Chloroquine as Antiviral Treatment in Coronavirus Infection 2020

Who this might be right for
COVID-19
Wroclaw Medical University 16
Testing effectiveness (Phase 2)Study completedNCT01610336
What this trial is testing

A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment

Who this might be right for
Non-small Cell Lung Cancer
Novartis Pharmaceuticals 161
Large-scale testing (Phase 3)Study completedNCT05986136
What this trial is testing

Dapagliflozin in Patients With Ulcerative Colitis

Who this might be right for
Inflammatory Bowel Diseases
Mostafa Bahaa 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06514807
What this trial is testing

Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia Patients

Who this might be right for
Essential Thrombocythaemia
AOP Orphan Pharmaceuticals AG 117
Testing effectiveness (Phase 2)Study completedNCT03723811
What this trial is testing

Clinical Study to Investigate the Efficacy and Safety of SJP002 Ophthalmic Solution in Patients With Dry Eye Syndrome.

Who this might be right for
Dry Eye Syndromes
Samjin Pharmaceutical Co., Ltd. 152
Testing effectiveness (Phase 2)Study completedNCT00004211
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 17
Next Page